REvenue guidance is up from pro forma $30m based on a full year of scanmedics, to $30 to 33m - which includes 9 months. However EBITDA has gone from proforma $4m (12mnth) to $3.5 to 4m (9mnth). About the same I guess.
REvenue guidance is up from pro forma $30m based on a full year...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $761.4M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.0¢ | 44.5¢ | $580.6K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 205599 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 321384 | 10 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PGC (ASX) Chart |